Ignite Creation Date:
2024-05-06 @ 7:37 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06077773
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2023-10-05
Brief Title:
Phase 2 Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria
Sponsor:
Organization:
Escient Pharmaceuticals Inc